NO852877L - Nye substituerte amider og deres fremstilling. - Google Patents

Nye substituerte amider og deres fremstilling.

Info

Publication number
NO852877L
NO852877L NO852877A NO852877A NO852877L NO 852877 L NO852877 L NO 852877L NO 852877 A NO852877 A NO 852877A NO 852877 A NO852877 A NO 852877A NO 852877 L NO852877 L NO 852877L
Authority
NO
Norway
Prior art keywords
radical
alkyloxy
alkyl
het
optionally substituted
Prior art date
Application number
NO852877A
Other languages
English (en)
Other versions
NO161673B (no
NO161673C (no
Inventor
Claude Cotrel
Claude Guyon
Gerard Roussel
Gerard Taurand
Original Assignee
Rhone Poulenc Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Sante filed Critical Rhone Poulenc Sante
Publication of NO852877L publication Critical patent/NO852877L/no
Publication of NO161673B publication Critical patent/NO161673B/no
Publication of NO161673C publication Critical patent/NO161673C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Quinoline Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO852877A 1984-07-19 1985-07-18 Analogifremgangsm te for fremstilling av nye, substituerte 1,8-naftyridin-2-yl-amider. NO161673C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8411442A FR2567887B1 (fr) 1984-07-19 1984-07-19 Nouveaux amides substitues, leur preparation et les medicaments qui les contiennent

Publications (3)

Publication Number Publication Date
NO852877L true NO852877L (no) 1986-01-20
NO161673B NO161673B (no) 1989-06-05
NO161673C NO161673C (no) 1989-09-13

Family

ID=9306273

Family Applications (1)

Application Number Title Priority Date Filing Date
NO852877A NO161673C (no) 1984-07-19 1985-07-18 Analogifremgangsm te for fremstilling av nye, substituerte 1,8-naftyridin-2-yl-amider.

Country Status (27)

Country Link
US (1) US4642308A (no)
EP (1) EP0172083B1 (no)
JP (1) JPS6163656A (no)
KR (1) KR860001100A (no)
AT (1) ATE33652T1 (no)
AU (1) AU572672B2 (no)
CA (1) CA1224787A (no)
CS (1) CS253730B2 (no)
DD (1) DD240011A5 (no)
DE (1) DE3562250D1 (no)
DK (1) DK327285A (no)
ES (1) ES8604584A1 (no)
FI (1) FI79313C (no)
FR (1) FR2567887B1 (no)
GR (1) GR851774B (no)
HU (1) HU199802B (no)
IL (1) IL75817A (no)
MA (1) MA20487A1 (no)
NO (1) NO161673C (no)
NZ (1) NZ212764A (no)
OA (1) OA08069A (no)
PH (1) PH21301A (no)
PL (1) PL145331B1 (no)
PT (1) PT80840B (no)
SU (1) SU1417797A3 (no)
YU (1) YU118785A (no)
ZA (1) ZA855409B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1265803A (fr) * 1985-07-11 1990-02-13 Claude Cotrel Amides substitues, leur preparation et les medicaments qui les contiennent
FR2592882B2 (fr) * 1986-01-16 1988-03-11 Rhone Poulenc Sante Nouveaux amides substitues, leur preparation et les medicaments qui les contiennent
US4753941A (en) * 1986-01-16 1988-06-28 Rhone-Poulenc Sante Amides based on certain 1,8-naphtyridine-2-amines useful as anxiolytics
US5197518A (en) * 1991-06-27 1993-03-30 Double Containment Systems Centering support assembly for double containment pipe systems
GB9711257D0 (en) * 1997-05-30 1997-07-30 Smithkline Beecham Plc Novel compounds
US6340690B1 (en) * 1999-02-22 2002-01-22 Bio-Chem Pharma Inc. Antiviral methods using [1,8]naphthyridine derivatives
TW200526631A (en) * 2003-10-07 2005-08-16 Renovis Inc Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
US20080300243A1 (en) * 2005-02-28 2008-12-04 Kelly Michael G Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same
US7576099B2 (en) 2005-02-28 2009-08-18 Renovis, Inc. Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
US20150011569A1 (en) * 2011-12-15 2015-01-08 Philadelphia Health & Education Corporation D/B/A Drexel University College Of Medicine NOVEL P13K p110 INHIBITORS AND METHODS OF USE THEREOF
CN105646487B (zh) * 2016-03-15 2017-12-05 红河学院 一类溴代1,8‑萘啶衍生物及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1006725A (fr) * 1948-08-31 1952-04-28 Cilag Spa Nouveaux dérivés de la naphtyridine et procédé pour leur préparation
GB661515A (en) * 1948-08-31 1951-11-21 Cilag Ltd Process for the production of naphthyridine derivatives
US3389142A (en) * 1966-09-29 1968-06-18 Bristol Myers Co Esters of 2-substituted 1, 2-dihydroquinoline-nu-carboxylic acids and thione acids
US3576809A (en) * 1968-05-06 1971-04-27 Miles Lab 2-substituted derivatives of 6-methoxyquinoline
US3624097A (en) * 1969-07-22 1971-11-30 Warner Lambert Co N-pyridine 5-aminooxazoles
US4466965A (en) * 1982-07-26 1984-08-21 American Hospital Supply Corporation Phthalazine compounds, compositions and use

Also Published As

Publication number Publication date
IL75817A (en) 1988-06-30
AU4509085A (en) 1986-01-23
DK327285A (da) 1986-01-20
FR2567887B1 (fr) 1986-12-19
DD240011A5 (de) 1986-10-15
ATE33652T1 (de) 1988-05-15
CA1224787A (fr) 1987-07-28
PH21301A (en) 1987-09-28
ES8604584A1 (es) 1986-02-01
DK327285D0 (da) 1985-07-18
YU118785A (en) 1988-10-31
NO161673B (no) 1989-06-05
FI79313C (fi) 1989-12-11
GR851774B (no) 1985-11-26
ZA855409B (en) 1986-04-30
KR860001100A (ko) 1986-02-22
FI852821L (fi) 1986-01-20
HUT40799A (en) 1987-02-27
PT80840B (pt) 1988-02-17
PL254570A1 (en) 1986-10-21
ES545336A0 (es) 1986-02-01
NO161673C (no) 1989-09-13
US4642308A (en) 1987-02-10
EP0172083B1 (fr) 1988-04-20
IL75817A0 (en) 1985-11-29
EP0172083A1 (fr) 1986-02-19
JPS6163656A (ja) 1986-04-01
CS253730B2 (en) 1987-12-17
HU199802B (en) 1990-03-28
FI852821A0 (fi) 1985-07-18
FI79313B (fi) 1989-08-31
PT80840A (fr) 1985-08-01
OA08069A (fr) 1987-03-31
SU1417797A3 (ru) 1988-08-15
AU572672B2 (en) 1988-05-12
NZ212764A (en) 1988-05-30
MA20487A1 (fr) 1986-04-01
PL145331B1 (en) 1988-09-30
FR2567887A1 (fr) 1986-01-24
DE3562250D1 (en) 1988-05-26

Similar Documents

Publication Publication Date Title
NO852877L (no) Nye substituerte amider og deres fremstilling.
DK289888A (da) 2-substitueret-e-kondenserede oe1,2,4,aatriazolooe1,5-caapyrimidiner, farmaceutiske praeparater og anvendelser deraf
GB9113628D0 (en) Heterocyclic derivatives
EP0422456A3 (en) Pyridine derivatives and their use in combating unwanted plant growth
ATE27818T1 (de) Pyrimidonderivate.
KR870007169A (ko) 치환 아미드 및 그 산부가염의 제조방법
FR2660313B1 (fr) Nouveau sulfonyl-phenyl-betha-d-thioxylosides, leur procede de preparation et leur utilisation en therapeutique.
NZ225771A (en) Heterocyclically-substituted chloroaniline derivatives and pharmaceutical compositions: processes for preparation
GR3000546T3 (en) Substituted amides, their preparation and pharmaceutical compositions containing them
DK163922C (da) 2,3-dihydro-3-phenyl-2-benzofuranonderivater, fremgangsmaader til deres fremstilling og farmaceutiske midler indeholdende dem
JO1697B1 (en) Pyridine derivatives
MY103817A (en) Chloroaniline derivatives